The mission of the Oklahoma Bioscience Association is to promote the growth of biosciences and life science in Oklahoma through partnership building, education and outreach, networking, policy development and publicity.
0%
The mission of the Oklahoma Bioscience Association is to promote the growth of biosciences and life science in Oklahoma through partnership building, education and outreach, networking, policy development and publicity.
A Vision for the Future
The Oklahoma BioScience Association, a 501(c)(3) corporation, was incorporated in the spring of 2008. OKBio was created in response to a study originally commissioned by the Greater Oklahoma City Chamber.
In 2004, the Greater Oklahoma City Chamber formed a Regional Bioscience Strategy Steering Committee to develop a vision for the region’s bioscience future and a road map outlining strategies and actions for achieving it.
A Statewide Focus
Recognizing that the potential for bioscience and life science growth encompassed the entire state, one of the report’s key recommendations was to create a statewide association to provide a focal point and driver for the state’s diverse and growing bioscience and life science community.
OKBio is the voice for Oklahoma’s dynamic and diverse bioscience and life science community. In collaboration with partners statewide, OKBio works to:
There is no cure for glioblastoma, the fatal brain cancer that claimed the lives of Sen. John McCain last year and Sen. Edward Kennedy in 2009.
Even with treatment, the median survival is 12 to 18 months. For most, a diagnosis is considered a death sentence.
But in Oklahoma, Mike Schuster has already more than doubled the life expectancy for patients with glioblastoma.
For more information, click here.
From viruses to cancer, and large molecules to nanoparticles, Oklahoma State University hosts a wide range of experts in the growing field of drug delivery research.
“Drug delivery research and development is a burgeoning area nationwide, and OSU researchers are playing major roles in this important aspect of medical science,” said Dr. Kenneth Sewell, vice president for research.
For more information, click here.
Ascend BioVentures puts a unique spin on the concept of pharmaceutical accelerators, says Elaine Hamm, Ph.D., the company’s founding CEO.
It is a lean operation that features its own crowd-sourcing element in a diverse, 12-member advisory committee.
“I think what we are doing as a model is very innovative.” Hamm said.
For more information, click here.
To begin the process, please complete the application linked below.
